Health experts redefine cardiovascular disease risk, prevention and management

Health experts are redefining cardiovascular disease (CVD) risk, prevention and management, according to a new American Heart Association presidential advisory published today in the Association’s flagship journal Circulation.

Despite new Wegovy coverage, Medicare patients may face high drug costs and other hurdles

Medicare confirmed this week that it will cover Novo Nordisk’s obesity drug Wegovy if prescribed to prevent heart problems, but policy experts said Medicare patients

March 22, 2024

Opinion | ‘Curable’: A Case for Precision of Language

Casey is a physician assistant. In the movie The Giver, the young protagonist Jonas asks a poignant question: “Father, do you love me?” His mother

December 20, 2023

David Khougazian joins Flagship to build ‘partnerships with different flavors’; Former Novo Nordisk exec to lead Evaxion

It’s a classic biopharma story. In January, David Khougazian bumped into Flagship Pioneering founder Noubar Afeyan at the JP Morgan healthcare conference. They caught up,

September 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.